Hepatocyte growth factor (HGF) is an important multifunctional cytokine whose gene expression is regulated mainly at the transcriptional level. Previous studies using transgenic mice as well as in vitro analyses showed that a potential regulatory element(s) exists between 7260 to 7230 bp in the upstream region of the HGF gene promoter. In the present study, we have discovered that this region is a composite site through which members of the nuclear factor 1 (NF1) and upstream stimulatory factor (USF) families bind to and regulate HGF gene transcription. Gel mobility shift and supershift assays revealed that USF and NF1 have high binding anity for this region and that the binding sites of the two dierent transcription factor families overlap. Functional studies showed that NF1 suppresses HGF gene promoter activity and that USF has an activating function. We found that the NF1/X and NF1/Red1 isoforms strongly suppressed HGF promoter activity while the NF1/L variant had no obvious eects. USF1, but not USF2, of the USF family stimulated HGF gene promoter activity. More interestingly, during liver regeneration after partial hepatectomy, a process which activates the HGF gene, we noted that the binding activity of USF to the HGF promoter element increased while that of NF1 decreased. These data provide insight into the molecular mechanisms that govern HGF gene transcription. Oncogene (2000) 19, 2786 ± 2790.
Keywords: hepatocyte growth factor; NF1; USF; promoter; partial hepatectomy; transcription Hepatocyte growth factor (HGF) is an important cytokine that is produced by stromal cells in a variety of tissues and aects neighboring epithelial cells in a paracrine fashion. It stimulates cell growth, cell motility and morphogenesis on its target cells through binding and activating its speci®c tyrosine kinase cell surface receptor known as c-Met (Tamagnone and Comoglio, 1997; Michalopoulos and DeFrances, 1997; Vande Woude et al., 1997; Zarnegar and Michalopoulos, 1995; Rubin et al., 1993) . Gene knock out studies have shown that HGF has an essential role in embryonic development (Schmidt et al., 1995; Uehara et al., 1995) . In adulthood, HGF also plays an important role in supporting the maintenance and renewal of cells in various organs including liver, lung and kidney.
HGF gene expression is regulated mainly at the transcriptional level. Therefore, elucidation of the mechanisms controlling HGF expression is critical for understanding the molecular basis of HGF's expression and function in physiological and pathological conditions. Toward this, our laboratory as well as others have shown that several potential transcriptional regulatory elements are present in the 5'-¯anking region of the HGF gene promoter (Aravamundan et al., 1993; Liu et al., 1994; Okajima et al., 1993; Plaschke-Schlutter et al., 1995) . Our previous studies demonstrated that several transcription factors, including estrogen receptor (ER) and chicken ovalbumin upstream promoter transcription factor (COUP-TF) (Jiang et al., 1997a) , C/EBP (Jiang and Zarnegar, 1997) , and Sp1 (Jiang et al., 1997b) , bind to the HGF promoter region and regulate its activity.
In vivo analysis of the HGF promoter using transgenic mice revealed that the upstream DNA element(s) located between 0.7 and 0.1 kb of the promoter region is absolutely essential for promoter activity (Bell et al., 1998) . DNase I footprinting using intact nuclei from regenerating mouse liver identi®ed several hypersensitive sites within the upstream region of the HGF promoter, one of which was mapped to a region approximately 0.3 kb from the transcription initiation site (Bell et al., 1998) . Similar results were obtained when intact nuclei from NIH3T3 cells were subjected to DNase I footprinting (Jiang et al., 1997b) . In vitro analysis of the HGF promoter using transient transfection of HGF-promoter constructs into NIH3T3 ®broblasts showed that a regulatory element(s) is present from 0.2 to 0.3 kb upstream of the promoter (Liu et al., 1994; Plashke-Schlutter et al., 1995) . Moreover, footprinting analysis showed speci®c interaction of nuclear protein with the promoter region at 7260 to 7230 bp (Plaschke-Schlutter et al., 1995) .
We analysed the nucleotide sequence of this 30 bp region by computer using MacVector software and, as indicated in Figure 1a , identi®ed putative binding sites such as NF1, AP2 and an E-box for bHLH-zip transfection factors (like USF and Myc/Max). This analysis also identi®ed several potential RGGTCA repeat sequences which form the binding site for transcription factors belonging to the nuclear receptor superfamily (Figure 1a) . The DNA sequence of the regulatory element of the HGF promoter is highly conserved in mouse, rat and human (Figure 1a ). To test whether the complex formed with the HGF promoter element relates to these putative sites, gel mobility band shift assays were carried out using the HGF promoter element as a probe and commercially available oligonucleotides for various binding sites as competitors. As shown in Figure 1b , only NF1 binding site was an eective competitor. Other sites such as the AP2 site and the E-box binding site did not aect this complex (Figure 1b , lanes 5, 6 and 8). Moreover, neither oligos containing binding sites for the nuclear receptor family members such as RARE (retinoid acid receptor response element), RXRE (retinoid X response element), TRE (thyroid hormone receptor response element) and NGF-IB (nerve growth factor induced-B) nor oligos having binding sites for AP1, SP1, C/EBP and NF-Y could eliminate the complex(es) bound to the HGF promoter element ( Figure 1b ). As mentioned above, only the NF1 consensus site showed competitive activity; however, as opposed to the competition with the unlabeled-self probe which was complete, the competition with the NF1 site was not complete and two complexes remained ( Figure 1b , lane 2 vs 3). Even when a large amount of NF1 oligo was used as a competitor, the two complexes still remained (data not presented). Thus, it is possible that the strong complex is composed of at least three dierent subcomplexes in which the potential NF1 binding complex masks the other two minor complexes. To further characterize the two minor bands, we made NF1-depleted nuclear protein extract from NIH3T3 cells by adding excess unlabeled NF1 oligo to the nuclear protein extract. This NF1-depleted nuclear protein extract was then used to perform gel mobility band shift competition assays using the radiolabeled HGF promoter element as a probe and various binding sites as competitors. As shown in Figure 1c , USF and Myc/ Max binding sites (E-box oligos) eectively eliminated the upper complex, which we have named C1 ( Figure  1c , lanes 1 and 2). On the other hand, the RGGTCAcontaining oligos such as RARE, RXRE, VDRE (vitamin D receptor response element), TRE and NGF-IB competed for the lower complex, which we have named C2 (Figure 1c , lanes 7 ± 11). Other oligos such as C/EBP, AP2, Sp1 and AP1 did not compete for C1 or C2 (Figure 1c , lanes 3 ± 6). Based on these results, we concluded that the regulatory region in the HGF gene promoter (7260 to 7230) could form at least three distinct complexes with the nuclear protein extract from NIH3T3 ®broblasts and that these complexes may be related to the NF1, E-box and nuclear receptor families of transcription factors.
To test whether NF1 protein is involved in the formation of the major complex(es), antibody against NF1 was used in supershift assays. As depicted in Figure 2a , anti-NF1 antiserum supershifted the major complex(es) (lanes 3 and 4). Control non-immune serum or anti-Sp1 antibody did not have any eect (Figure 2a , lanes 5 and 6). The anti-NF1 antibody we used is against the N-terminal highly conserved region of NF1 and recognizes all NF1 isoforms. To con®rm that the HGF promoter element can bind to NF1 protein, we also used NF1 protein puri®ed from rat liver and performed gel mobility band shift assays. NF1 protein speci®cally bound to this region when this element was radiolabeled and used as a probe (data not shown). Competition experiments were performed using oligonucleotides corresponding to the binding sites for several transcription factors such as NF1, AP-2, USF, Myc/Max, RARE, RXRE, TRE(Pal), TRE(DR4), NGF-IB, Sp1, C/EBP, AP1 and E2A purchased from Santa Cruz Biotechnology, Inc. (c) Experiments were carried out as those outlined in (b); however, excess NF1 oligo was added to the nuclear protein extract to generate NF1-depleted nuclear protein extract. This depleted extract was then used with the indicated oligonucleotides as competitors. In both (b) and (c), the nuclear protein extract was from NIH3T3 cells. The probe was labeled wild-type promoter element (7260 to 7230 bp). Competitors were added at a 100-fold molar excess. Nuclear protein extracts and binding reactions were prepared as we described previously (Jiang et al., 1997a) . C1 denotes complex 1; C2 denotes complex 2; F denotes free probe
The results from competition assays showed that E-box containing oligos (USF and Myc/Max) could eliminate the upper complex (C1) formed in NF1-depleted nuclear protein extract (Figure 1c) . We then reasoned that C1 may be composed of one or more members of the bHLH transcription factor family that bind to the HGF promoter E-box motif. Therefore, antibodies against these transcription factors were used to perform gel supershift assays. Anti-USF1 or anti-USF2 antibodies could partially shift complex C1 (Figure 2b, lanes 3 and 4) . A mixture of anti-USF1 plus anti-USF2 totally shifted complex C1 (Figure 2b, lane 5) . Antibodies against Myc, Max, SREBP and E2A did not have any eect (Figure 2b, lanes 6 ± 12) . Also unrelated antibodies such as anti-Ap2, Sp1 and C/EBP did not recognize the C1 complex. These data revealed that the transcription factors of the USF family bind to this region and form complex C1. The promoter element has potential RGGTCA sequences; and since several conserved sequences containing RGGTCA strongly competed for complex C2 (Figure 1c) , it is possible that complex C2 is composed of member(s) of the nuclear receptor superfamily. Thus, antibodies against members of the nuclear receptor family were used to perform gel supershift assays; these included antibodies against RAR, RXR, TR, COUP-TF, VDR and NGF-IB. None of them reacted with complex C2 (data not shown).
To test the functionality of the identi®ed binding sites and their cognate transcription factors in regulating HGF promoter activity, we created two dierent mutated constructs in the context of the 0.7 HGF-CAT construct by sequential PCR site directed mutagenesis. In one construct, the NF1 binding site was mutated so that its binding ability is abolished. We named this construct 0.7 HGF-CAT/NF1-M (Figure 3a) . In another construct, we mutated the Ebox site (USF binding site) and named this construct 0.7 HGF-CAT/USF-M (Figure 3a) . These constructs were transfected into NIH3T3 cells along with the wild-type 0.7 HGF-CAT to determine promoter activity. Compared with the activity of the wild-type 0.7 HGF-CAT construct, the CAT activity of 0.7 HGF-CAT/NF1-M increased about threefold while that of the 0.7 HGF-CAT/USF-M decreased about 50% (Figure 3b ,c, the control bars). These results indicate that the NF1 site/NF-1 transcription factor suppress, but USF site/USF transcription factor upregulate, HGF gene promoter activity. To test whether these transcription factors indeed regulate the activity of the HGF promoter, we cotransfected the expression vectors encoding these transcription factors with the 0.7 HGF-CAT construct and its mutated forms. NF1 represents a family of sequencespeci®c DNA-binding proteins, which includes heterogeneous species resulting from either alternative splicing events of a single gene (Kruse and Sippel, 1994; Santoro et al., 1988) or transcription of multiple genes (Gil et al., 1988) . More than a dozen NF1 isoforms have been cloned to date (Kruse and Sippel, 1994) . We used the well-characterized NF1/Red1, NF1/X and NF1/L isoforms to perform co-transfection assays with the wild-type and mutated 0.7 HGF-CAT vectors in NIH3T3 ®broblasts. Results showed that NF1/Red1 and NF1/X suppressed promoter activity of the wild-type 0.7 HGF-CAT and the 0.7 HGF-CAT/USF-M constructs, but not that of the 0.7 HGF-CAT/NF1-M construct, in which the NF1 site is mutated (Figure 3b) . Interestingly, the NF1/L isoform did not aect the activity of the HGF promoter (Figure 3b ). It has been proposed that the regulatory function of NF1 depends on its co-activators and corepressors which interact with NF1's C-terminal region containing the protein ± protein interaction domain (Gao and Kunos, 1998) . It is possible that NF1/X and NF1/Red1 interact with a co-repressor required for the repressive function of NF1 on the HGF gene promoter, but that NF1/L lacks this protein ± protein interacting region accounting for its inactivity. a b Figure 2 Identi®cation of the major binding complex as NF1 transcription factor and the C1 complex as USF transcription factor. (a) Gel mobility supershift assay using a speci®c antiserum against NF1, which recognizes all NF1 isoforms, was carried out. Lane 1 is free probe. NI is non-immune serum. NPE were from NIH3T3 cells. (b) Complex C1 bound to the regulatory element was supershifted by anti-USF1 and/or anti-USF2 antibodies. Anti-Myc, anti-Max, anti-AP2, anti-SREBPb, antiSp1, and anti-E2A antibodies (from Santa Cruz Biotechnology, Inc) were also used for comparison. The probe was labeled wildtype promoter element (7260 to 7230 bp). C1 denotes complex 1; C2 denotes complex 2; S denotes supershift complex; F denotes free probe. The supershift assays were done as described previously (Jiang et al., 1997a) . In (b) NF1-depleted nuclear protein extract from NIH3T3 cells was used USF proteins are members of the basic-helix ± loop ± helix (bHLH) family of transcription factors (Carthew et al., 1985; Sawadogo and Roeder, 1985) . Two dierent genes encode USF1 and USF2 (Gregor et al., 1990) . They are highly divergent in their N-terminal sequences but share conserved C-terminal bHLH-zip dimerization and DNA-binding domains (Sirito et al., 1992) . USF binds DNA as a dimer at speci®c sites that are characterized by a central CANNTG (Gregor et al., 1990; Sawadogo and Roeder, 1985) . The data in Figure 3c show that USF1, but not USF2, directly stimulated HGF gene promoter activity. The transcriptional activation domains identi®ed in both USF1 and USF2 are located in the divergent N-terminal regions, suggesting that the cellular functions of the dierent a b c Figure 3 Functional analysis of the binding sites for complex C1 and NF1 within the HGF gene promoter. (a) Diagrammatic representation of the wild-type HGF-CAT reporter construct (0.7 HGF-CAT) and mutated HGF-CAT reporter plasmids (0.7 HGF-CAT/NF1-M and 0.7 HGF-CAT/USF-M) which harbor mutations in the NF1 and USF binding sites, respectively. The nucleotide sequence corresponding to position 7260 to 7230 bp in the mouse HGF promoter region is shown, and lower case letters indicate the mutated nucleotides. Construction of the 0.7 mouse HGF-CAT promoter construct (7699 to +29 bp) was described in an earlier work from our laboratory (Liu et al., 1994) . To generate the 0.7 HGF-CAT/NF1-M in which the NF1 binding site was mutated, sense (7230 to 7255) (5'-AAAGGT-CACCTGGCCCGAGGAAAGCT-3') and anti-sense (7255 to 7230) (5'-AGCTTTCCTCGGGCCAGGTGACCTTT-3') oligonucleotide primers containing the point mutations underlined were synthesized and used in sequential PCR ampli®cation steps. The primer pairs used in the sequential steps were sense primers with primer F (7298 to 7274) (5'-CGGATAGGAGCCACAAG-GATCTGGA-3') containing a SacI site and anti-sense primer with primer R (749 to 772) (5'-TGTGTGATTAACTGGAAA-GATCTAG-3') containing a BglII site. The template used in the sequential PCR was the 0.7 HGF-CAT construct. The two PCR products were combined and ampli®ed by primer 1 and primer 2. The ®nal PCR product was digested by SacI and BglII and subcloned into the corresponding SacI and BglII sites of the 0.7 HGF-CAT. To make the 0.7 HGF-CAT/USF-M in which the USF binding site was mutated, the same method as above was applied except these sense (7230 to 7255) (5'-AAAGGT-CAATTGGCCCGAGGCCAGCT-3') and anti-sense (7255 to 7230) (5'-AGCTGGCCTCGGGCCAATTGACCTTT-3') primers were used for creating the mutated USF binding site. (b) NIH3T3 cells were transiently transfected with the HGF-CAT constructs described above. Five mg of each of the HGF-CAT reporter plasmids (0.7 HGF-CAT/USF-M, 0.7 HGF-CAT/NF1-M or the wild-type 0.7 HGF-CAT) were cotransfected along with 2 mg of either NF1/X, NF1/Red1 or NF1/L expression vectors into the NIH3T3 cells. (c) Five mg of 0.7 HGF-CAT/NF1-M, 0.7 HGF-CAT/USF-M or the wild-type 0.7 HGF-CAT reporter constructs along with 2 mg of the USF1 or USF2 expression vectors were co-transfected into NIH3T3 ®broblasts. In (b) and (c) the data are presented as relative CAT activity (% conversion) and are from three independent experiments performed in duplicate. Error bars represent the standard deviation. Controls received empty vector (no insert). CAT activity was performed and determined as described previously (Jiang et al., 1997a) Figure 4 Changes in the binding activities of the USF and NF1 transcription factors to the HGF promoter element after 2/3 partial hepatectomy. Electrophoretic mobility band shift assays were performed in the presence of mouse liver nuclear extracts prepared at dierent time points including 0 (control), 3, 6 and 12 h after partial hepatectomy (PHX). In lanes 2, 4, 6 and 8, NF1 oligonucleotide (506) was used to eliminate NF1 binding. The probe was radiolabeled HGF promoter regulatory element (7260 to 7230 bp). The thick arrowhead points to the major complex composed of NF1 (C); C1 and C2 are indicated by thin arrows and denote the minor complexes; F denotes free probe. For preparation of mouse liver nuclear extracts, livers were removed from mice at 0, 3, 6 and 12 h after partial hepatectomy and homogenized in buer A containing protease inhibitors (Jiang et al., 1997a) . The nuclei were collected, and the nuclear protein was extracted by the same method as described in Figure 1 USF family members may not be completely redundant (Luo and Sawadogo, 1996) . This is probably the reason why USF1, but not USF2, stimulates the HGF gene promoter.
It is known that HGF promoter activity and the amount of HGF mRNA are up-regulated in the remnant liver after partial hepatectomy (Bell et al., 1998; Kono et al., 1992) . NF1 transcription factor is also downregulated in the liver after partial hepatectomy in rat (Gao et al., 1996) . To demonstrate whether any changes in the binding activity of NF1 for the composite regulatory element in the HGF promoter region after partial hepatectomy occur, we made nuclear protein extracts from mouse liver tissue at dierent time points after 70% partial hepatectomy and performed gel shift assays using the radiolabeled promoter element (7260 to 7230 bp) as a probe. The results showed that the overall binding activity of NF1 to this DNA region was decreased after partial hepatectomy (Figure 4, compare lanes 1, 3, 5 and 7) . Our data also demonstrated for the ®rst time that partial hepatectomy upregulates the binding activity of USF transcription factor as demonstrated by its enhanced binding to this composite site (Figure 4 , lanes 2, 4, 6 and 8; C1 complex shown by an arrow). The changes in the binding activity of USF were noted by 3 h post partial hepatectomy (Figure 4, lane 3) . Supershift assays using speci®c antibodies against USF1 and USF2 showed that C1 is indeed USF (data not shown). These data have led us to hypothesize that the changes in the binding activities of NF1 and USF correlate with the up-regulation of HGF gene expression in the liver after partial hepatectomy and may have physiological relevance.
